RUNX2 and acute myeloid leukemia: CD123 expression was evaluated on human AML cell lines MV4-11, TF1, Molm-13, OCI-Ly19, and OCI-AML3, and the CD123neg murine T cell lymphoma cell line EL4, as well as EL4 cells transfected with CD123.